{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:09:50Z","timestamp":1774552190024,"version":"3.50.1"},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T00:00:00Z","timestamp":1668470400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100006095","name":"by the Norwegian Multiregional Health Authorities","doi-asserted-by":"publisher","award":["2015113"],"award-info":[{"award-number":["2015113"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2013089"],"award-info":[{"award-number":["2013089"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Neurol"],"published-print":{"date-parts":[[2023,3]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>Complete recovery after adequately treated neuroborreliosis is common, but studies report that some patients experience persistent symptoms like self-reported cognitive problems and fatigue. Persisting symptoms are often termed post-Lyme disease syndrome, of which etiology is not clearly understood. The aim of this study was to investigate cognitive function, possible structural changes in brain regions and level of fatigue. We have not found previous studies on neuroborreliosis that use standardized neuropsychological tests and MRI with advanced image processing to investigate if there are subtle regional changes in cortical thickness and brain volumes after treatment.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>We examined 68 patients treated for neuroborreliosis 6\u00a0months earlier and 66 healthy controls, with a comprehensive neuropsychological test protocol, quantitative structural MRI analysis of the brain and Fatigue Severity Scale.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found no differences between the groups in either cognitive function, cortical thickness or brain volumes. The patients had higher score on Fatigue Severity Scale 3.8 vs. 2.9 (<jats:italic>p<\/jats:italic>\u2009=\u20090.001), and more patients (25.4%) than controls (5%) had severe fatigue (<jats:italic>p<\/jats:italic>\u2009=\u20090.002), but neither mean score nor proportion of patients with severe fatigue differed from findings in the general Norwegian population.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The prognosis regarding cognitive function, brain MRI findings and fatigue after adequately treated neuroborreliosis is favorable.<\/jats:p><\/jats:sec>","DOI":"10.1007\/s00415-022-11463-7","type":"journal-article","created":{"date-parts":[[2022,11,15]],"date-time":"2022-11-15T20:20:49Z","timestamp":1668543649000},"page":"1430-1438","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Assessment of cognitive function, structural brain changes and fatigue 6\u00a0months after treatment of neuroborreliosis"],"prefix":"10.1007","volume":"270","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1668-5799","authenticated-orcid":false,"given":"Silje","family":"Andreassen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth Margrete Stokke","family":"Lindland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mona Kristiansen","family":"Beyer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne Marit","family":"Solheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Unn","family":"Lj\u00f8stad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5se","family":"Mygland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c5slaug Rudjord","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Harald","family":"Reiso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Knut J\u00f8rgen","family":"Bjuland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Are Hugo","family":"Pripp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hanne Flinstad","family":"Harbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gro Christine Christensen","family":"L\u00f8haugen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi","family":"Eikeland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,11,15]]},"reference":[{"issue":"1","key":"11463_CR1","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1468-1331.2009.02756.x","volume":"17","author":"U Ljostad","year":"2010","unstructured":"Ljostad U, Mygland A (2010) Remaining complaints 1 year after treatment for acute Lyme neuroborreliosis; frequency, pattern and risk factors. Eur J Neurol 17(1):118\u2013123","journal-title":"Eur J Neurol"},{"issue":"5","key":"11463_CR2","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1111\/j.1600-0404.2010.01482.x","volume":"124","author":"R Eikeland","year":"2011","unstructured":"Eikeland R et al (2011) European neuroborreliosis: quality of life 30 months after treatment. Acta Neurol Scand 124(5):349\u2013354","journal-title":"Acta Neurol Scand"},{"issue":"3","key":"11463_CR3","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1093\/cid\/ciw299","volume":"63","author":"K Ogrinc","year":"2016","unstructured":"Ogrinc K et al (2016) Course and outcome of early European Lyme Neuroborreliosis (Bannwarth syndrome): clinical and laboratory findings. Clin Infect Dis 63(3):346\u2013353","journal-title":"Clin Infect Dis"},{"key":"11463_CR4","doi-asserted-by":"publisher","DOI":"10.1016\/j.lanepe.2021.100142","volume":"6","author":"J Ursinus","year":"2021","unstructured":"Ursinus J et al (2021) Prevalence of persistent symptoms after treatment for lyme borreliosis: a prospective observational cohort study. Lancet Reg Health Eur 6:100142","journal-title":"Lancet Reg Health Eur"},{"key":"11463_CR5","doi-asserted-by":"publisher","DOI":"10.1002\/brb3.2719","volume":"12","author":"AH Sigurdardottir","year":"2022","unstructured":"Sigurdardottir AH et al (2022) Fatigue and cognitive impairment in neuroborreliosis patients posttreatment\u2014a neuropsychological retrospective cohort study. Brain Behav 12:e2719","journal-title":"Brain Behav"},{"issue":"9","key":"11463_CR6","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1086\/508667","volume":"43","author":"GP Wormser","year":"2006","unstructured":"Wormser GP et al (2006) The clinical assessment, treatment, and prevention of lyme disease, human granulocytic anaplasmosis, and babesiosis: clinical practice guidelines by the Infectious Diseases Society of America. Clin Infect Dis 43(9):1089\u20131134","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11463_CR7","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1093\/cid\/ciy019","volume":"67","author":"EA Eckman","year":"2018","unstructured":"Eckman EA et al (2018) Neuroimmunomodulators in neuroborreliosis and lyme encephalopathy. Clin Infect Dis 67(1):80\u201388","journal-title":"Clin Infect Dis"},{"issue":"1","key":"11463_CR8","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1186\/s12974-018-1381-4","volume":"15","author":"JM Coughlin","year":"2018","unstructured":"Coughlin JM et al (2018) Imaging glial activation in patients with post-treatment Lyme disease symptoms: a pilot study using [(11)C]DPA-713 PET. J Neuroinflamm 15(1):346","journal-title":"J Neuroinflamm"},{"issue":"8","key":"11463_CR9","doi-asserted-by":"publisher","first-page":"1937","DOI":"10.1007\/s00415-019-09359-0","volume":"266","author":"A Garkowski","year":"2019","unstructured":"Garkowski A et al (2019) Neuronal loss or dysfunction in patients with early Lyme neuroborreliosis: a proton magnetic resonance spectroscopy study of the brain. J Neurol 266(8):1937\u20131943","journal-title":"J Neurol"},{"issue":"3","key":"11463_CR10","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1111\/j.1468-1331.2011.03563.x","volume":"19","author":"R Eikeland","year":"2012","unstructured":"Eikeland R et al (2012) European neuroborreliosis: neuropsychological findings 30 months post-treatment. Eur J Neurol 19(3):480\u2013487","journal-title":"Eur J Neurol"},{"key":"11463_CR11","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1093\/arclin\/acy051","volume":"34","author":"P Touradji","year":"2018","unstructured":"Touradji P et al (2018) Cognitive decline in post-treatment Lyme disease syndrome. Arch Clin Neuropsychol 34:455\u2013465","journal-title":"Arch Clin Neuropsychol"},{"key":"11463_CR12","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1093\/arclin\/acy083","volume":"34","author":"JG Keilp","year":"2018","unstructured":"Keilp JG et al (2018) Neurocognition in post-treatment Lyme disease and major depressive disorder. Arch Clin Neuropsychol 34:466\u2013480","journal-title":"Arch Clin Neuropsychol"},{"issue":"1","key":"11463_CR13","first-page":"72","volume":"12","author":"DA Pollina","year":"1999","unstructured":"Pollina DA et al (1999) Cognitive processing speed in Lyme disease. Neuropsychiatry Neuropsychol Behav Neurol 12(1):72\u201378","journal-title":"Neuropsychiatry Neuropsychol Behav Neurol"},{"issue":"1","key":"11463_CR14","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1186\/s12879-019-4452-y","volume":"19","author":"A Berende","year":"2019","unstructured":"Berende A et al (2019) Cognitive impairments in patients with persistent symptoms attributed to Lyme disease. BMC Infect Dis 19(1):833","journal-title":"BMC Infect Dis"},{"issue":"11","key":"11463_CR15","doi-asserted-by":"publisher","first-page":"2572","DOI":"10.1007\/s00415-015-7891-4","volume":"262","author":"R Dersch","year":"2015","unstructured":"Dersch R et al (2015) Quality of life, fatigue, depression and cognitive impairment in Lyme neuroborreliosis. J Neurol 262(11):2572\u20132577","journal-title":"J Neurol"},{"issue":"1","key":"11463_CR16","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1148\/radiol.2531081103","volume":"253","author":"R Agarwal","year":"2009","unstructured":"Agarwal R, Sze G (2009) Neuro-Lyme disease: MR imaging findings. Radiology 253(1):167\u2013173","journal-title":"Radiology"},{"key":"11463_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2020.117176","volume":"419","author":"M \u00d8rb\u00e6k","year":"2020","unstructured":"\u00d8rb\u00e6k M et al (2020) CT and MR neuroimaging findings in patients with Lyme neuroborreliosis: a national prospective cohort study. J Neurol Sci 419:117176","journal-title":"J Neurol Sci"},{"key":"11463_CR18","doi-asserted-by":"publisher","DOI":"10.1007\/s00234-022-02957-2","author":"ES Lindland","year":"2022","unstructured":"Lindland ES et al (2022) Enhancement of cranial nerves in Lyme neuroborreliosis: incidence and correlation with clinical symptoms and prognosis. Neuroradiology. https:\/\/doi.org\/10.1007\/s00234-022-02957-2","journal-title":"Neuroradiology"},{"issue":"1","key":"11463_CR19","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1186\/s12967-020-02455-0","volume":"18","author":"EJ Lim","year":"2020","unstructured":"Lim EJ, Son CG (2020) Review of case definitions for myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS). J Transl Med 18(1):289","journal-title":"J Transl Med"},{"key":"11463_CR20","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.nicl.2017.09.024","volume":"17","author":"A Finkelmeyer","year":"2018","unstructured":"Finkelmeyer A et al (2018) Grey and white matter differences in Chronic Fatigue Syndrome\u2014a voxel-based morphometry study. Neuroimage Clin 17:24\u201330","journal-title":"Neuroimage Clin"},{"key":"11463_CR21","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.848730","volume":"16","author":"K Thapaliya","year":"2022","unstructured":"Thapaliya K et al (2022) Alteration of cortical volume and thickness in myalgic encephalomyelitis\/chronic fatigue syndrome. Front Neurosci 16:848730","journal-title":"Front Neurosci"},{"issue":"6","key":"11463_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmjopen-2018-027083","volume":"9","author":"AM Solheim","year":"2019","unstructured":"Solheim AM, Ljostad U, Mygland A (2019) Six versus two weeks treatment with doxycycline in Lyme neuroborreliosis: the protocol of a multicentre, non-inferiority, double-blinded and randomised controlled trial. BMJ Open 9(6):e027083","journal-title":"BMJ Open"},{"issue":"1","key":"11463_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1111\/j.1468-1331.2009.02862.x","volume":"17","author":"A Mygland","year":"2010","unstructured":"Mygland A et al (2010) EFNS guidelines on the diagnosis and management of European Lyme neuroborreliosis. Eur J Neurol 17(1):8-16.e1\u20134","journal-title":"Eur J Neurol"},{"issue":"3","key":"11463_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.ttbdis.2021.101678","volume":"12","author":"S Andreassen","year":"2021","unstructured":"Andreassen S et al (2021) Cognitive function, fatigue and Fazekas score in patients with acute neuroborreliosis. Ticks Tick Borne Dis 12(3):101678","journal-title":"Ticks Tick Borne Dis"},{"key":"11463_CR25","volume-title":"Wechsler adult intelligence scale","author":"D Wechsler","year":"2008","unstructured":"Wechsler D (2008) Wechsler adult intelligence scale, 4th edn. NCS Pearson Inc., San Antonio","edition":"4"},{"key":"11463_CR26","volume-title":"Delis-Kaplan executive function system (D-KEFS)","author":"DC Delis","year":"2001","unstructured":"Delis DC, Kaplan E, Kramer JH (2001) Delis-Kaplan executive function system (D-KEFS). The Psychological Corporation, San Antonio"},{"key":"11463_CR27","volume-title":"California verbal learning test","author":"DJ Delis","year":"2000","unstructured":"Delis DJ et al (2000) California verbal learning test, 2 (Adult Version). The Psychological Corporation, San Antonio","edition":"2 (Adult Versio"},{"key":"11463_CR28","volume-title":"Wechsler memory scale","author":"D Wechsler","year":"1997","unstructured":"Wechsler D (1997) Wechsler memory scale, 3rd edn. The Psychological Corporation, San Antonio","edition":"3"},{"issue":"10","key":"11463_CR29","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1001\/archneur.1989.00520460115022","volume":"46","author":"LB Krupp","year":"1989","unstructured":"Krupp LB et al (1989) The fatigue severity scale. Application to patients with multiple sclerosis and systemic lupus erythematosus. Arch Neurol 46(10):1121\u20131123","journal-title":"Arch Neurol"},{"issue":"2","key":"11463_CR30","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1080\/14034940410028406","volume":"33","author":"A Lerdal","year":"2005","unstructured":"Lerdal A et al (2005) Fatigue in the general population: a translation and test of the psychometric properties of the Norwegian version of the fatigue severity scale. Scand J Public Health 33(2):123\u2013130","journal-title":"Scand J Public Health"},{"issue":"2","key":"11463_CR31","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1006\/nimg.1998.0395","volume":"9","author":"AM Dale","year":"1999","unstructured":"Dale AM, Fischl B, Sereno MI (1999) Cortical surface-based analysis. I. Segmentation and surface reconstruction. Neuroimage 9(2):179\u2013194","journal-title":"Neuroimage"},{"issue":"2","key":"11463_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1006\/nimg.1998.0396","volume":"9","author":"B Fischl","year":"1999","unstructured":"Fischl B, Sereno MI, Dale AM (1999) Cortical surface-based analysis. II: Inflation, flattening, and a surface-based coordinate system. Neuroimage 9(2):195\u2013207","journal-title":"Neuroimage"},{"issue":"20","key":"11463_CR33","doi-asserted-by":"publisher","first-page":"11050","DOI":"10.1073\/pnas.200033797","volume":"97","author":"B Fischl","year":"2000","unstructured":"Fischl B, Dale AM (2000) Measuring the thickness of the human cerebral cortex from magnetic resonance images. Proc Natl Acad Sci U S A 97(20):11050\u201311055","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"Suppl 1","key":"11463_CR34","doi-asserted-by":"publisher","first-page":"S69","DOI":"10.1016\/j.neuroimage.2004.07.016","volume":"23","author":"B Fischl","year":"2004","unstructured":"Fischl B et al (2004) Sequence-independent segmentation of magnetic resonance images. Neuroimage 23(Suppl 1):S69-84","journal-title":"Neuroimage"},{"issue":"3","key":"11463_CR35","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1016\/j.neuroimage.2006.01.021","volume":"31","author":"RS Desikan","year":"2006","unstructured":"Desikan RS et al (2006) An automated labeling system for subdividing the human cerebral cortex on MRI scans into gyral based regions of interest. Neuroimage 31(3):968\u2013980","journal-title":"Neuroimage"},{"key":"11463_CR36","volume-title":"IBM SPSS statistics for windows, version 28.0","author":"I Corp","year":"2021","unstructured":"Corp I (2021) IBM SPSS statistics for windows, version 28.0. IBM Corp, Armonk"},{"issue":"1","key":"11463_CR37","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y (1995) Controlling the false discovery rate: a practical and powerful approach to multiple testing. J Roy Stat Soc: Ser B (Methodol) 57(1):289\u2013300","journal-title":"J Roy Stat Soc: Ser B (Methodol)"},{"issue":"5","key":"11463_CR38","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1111\/j.1600-0404.1995.tb07020.x","volume":"91","author":"T Benke","year":"1995","unstructured":"Benke T et al (1995) Lyme encephalopathy: long-term neuropsychological deficits years after acute neuroborreliosis. Acta Neurol Scand 91(5):353\u2013357","journal-title":"Acta Neurol Scand"},{"key":"11463_CR39","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1017\/S1355617706060231","volume":"12","author":"JG Keilp","year":"2006","unstructured":"Keilp JG et al (2006) WAIS-III and WMS-III performance in chronic Lyme disease. J Int Neuropsychol Soc 12:119\u2013129","journal-title":"J Int Neuropsychol Soc"},{"key":"11463_CR40","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1186\/s12883-015-0386-1","volume":"15","author":"H Schmidt","year":"2015","unstructured":"Schmidt H et al (2015) Neurocognitive functions and brain atrophy after proven neuroborreliosis: a case-control study. BMC Neurol 15:139","journal-title":"BMC Neurol"},{"key":"11463_CR41","first-page":"1145","volume-title":"The WAIS-III and major depression: absence of VIQ\/PIQ differences","author":"M Gorlyn","year":"2006","unstructured":"Gorlyn M et al (2006) The WAIS-III and major depression: absence of VIQ\/PIQ differences. Lisse, pp 1145\u20131157"},{"key":"11463_CR42","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1136\/jnnp-2022-329724","volume":"93","author":"AM Solheim","year":"2022","unstructured":"Solheim AM et al (2022) Six versus 2 weeks treatment with doxycycline in European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blinded, randomised and placebo-controlled trial. J Neurol Neurosurg Psychiatry 93:1222\u20131228","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"11463_CR43","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/S1474-4422(08)70119-4","volume":"7","author":"U Ljostad","year":"2008","unstructured":"Ljostad U et al (2008) Oral doxycycline versus intravenous ceftriaxone for European Lyme neuroborreliosis: a multicentre, non-inferiority, double-blind, randomised trial. Lancet Neurol 7(8):690\u2013695","journal-title":"Lancet Neurol"},{"issue":"5","key":"11463_CR44","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1037\/neu0000550","volume":"33","author":"O Rasouli","year":"2019","unstructured":"Rasouli O et al (2019) Neuropsychological dysfunction in chronic fatigue syndrome and the relation between objective and subjective findings. Neuropsychology 33(5):658\u2013669","journal-title":"Neuropsychology"},{"issue":"7","key":"11463_CR45","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1093\/geronb\/gbw207","volume":"73","author":"ZZ Zlatar","year":"2018","unstructured":"Zlatar ZZ et al (2018) Subjective cognitive decline correlates with depression symptoms and not with concurrent objective cognition in a clinic-based sample of older adults. J Gerontol B Psychol Sci Soc Sci 73(7):1198\u20131202","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"11463_CR46","doi-asserted-by":"publisher","first-page":"4295","DOI":"10.1007\/s10067-021-05760-1","volume":"40","author":"H van Middendorp","year":"2021","unstructured":"van Middendorp H et al (2021) Expectancies as predictors of symptom improvement after antimicrobial therapy for persistent symptoms attributed to Lyme disease. Clin Rheumatol 40:4295\u20134308","journal-title":"Clin Rheumatol"},{"issue":"4","key":"11463_CR47","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1007\/s11920-013-0353-8","volume":"15","author":"Y Christley","year":"2013","unstructured":"Christley Y et al (2013) The neuropsychiatric and neuropsychological features of chronic fatigue syndrome: revisiting the enigma. Curr Psychiatry Rep 15(4):353","journal-title":"Curr Psychiatry Rep"},{"issue":"1","key":"11463_CR48","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1186\/s12967-020-02506-6","volume":"18","author":"ZY Shan","year":"2020","unstructured":"Shan ZY et al (2020) Neuroimaging characteristics of myalgic encephalomyelitis\/chronic fatigue syndrome (ME\/CFS): a systematic review. J Transl Med 18(1):335","journal-title":"J Transl Med"}],"container-title":["Journal of Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00415-022-11463-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00415-022-11463-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,8]],"date-time":"2024-10-08T07:43:58Z","timestamp":1728373438000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00415-022-11463-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,11,15]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["11463"],"URL":"https:\/\/doi.org\/10.1007\/s00415-022-11463-7","relation":{},"ISSN":["0340-5354","1432-1459"],"issn-type":[{"value":"0340-5354","type":"print"},{"value":"1432-1459","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,11,15]]},"assertion":[{"value":"16 October 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 October 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 November 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Author \u00c5slaug R. Lorentzen received minor grant from Sanofi. The authors have no relevant financial or non-financial interests to disclose.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The study was approved by the Norwegian Regional Committee for Medical and Health Research Ethics, the South-Eastern region (2015\/1031 and 2015\/1588) as well as through local routines at S\u00f8rlandet Hospital and Oslo University Hospital.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Participants gave informed consent to participate in the study before taking part.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}}]}}